NN Group Valuation

Is 0QVV undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

6/6

Valuation Score 6/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 0QVV when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 0QVV (€42.62) is trading below our estimate of fair value (€102.64)

Significantly Below Fair Value: 0QVV is trading below fair value by more than 20%.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for 0QVV?

Key metric: As 0QVV is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for 0QVV. This is calculated by dividing 0QVV's market cap by their current earnings.
What is 0QVV's PE Ratio?
PE Ratio10x
Earnings€1.17b
Market Cap€11.68b

Price to Earnings Ratio vs Peers

How does 0QVV's PE Ratio compare to its peers?

The above table shows the PE ratio for 0QVV vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average41.8x
LGEN Legal & General Group
46.3x27.5%UK£13.0b
PRU Prudential
24.7x27.6%UK£17.1b
JUST Just Group
17.9x8.2%UK£1.6b
CSN Chesnara
78.2x11.8%UK£391.1m
0QVV NN Group
10x12.1%€11.7b

Price-To-Earnings vs Peers: 0QVV is good value based on its Price-To-Earnings Ratio (10x) compared to the peer average (41.8x).


Price to Earnings Ratio vs Industry

How does 0QVV's PE Ratio compare vs other companies in the European Insurance Industry?

1 CompanyPrice / EarningsEstimated GrowthMarket Cap
0QVV 10.0xIndustry Avg. 12.0xNo. of Companies15PE0816243240+
1 CompanyEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: 0QVV is good value based on its Price-To-Earnings Ratio (10x) compared to the European Insurance industry average (12x).


Price to Earnings Ratio vs Fair Ratio

What is 0QVV's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

0QVV PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio10x
Fair PE Ratio14.9x

Price-To-Earnings vs Fair Ratio: 0QVV is good value based on its Price-To-Earnings Ratio (10x) compared to the estimated Fair Price-To-Earnings Ratio (14.9x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 0QVV forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current€42.62
€52.51
+23.2%
8.2%€63.00€42.95n/a16
Nov ’25€45.81
€51.65
+12.8%
9.5%€63.00€42.95n/a16
Oct ’25€44.55
€51.72
+16.1%
9.5%€63.00€42.95n/a16
Sep ’25€44.24
€51.78
+17.0%
9.9%€63.00€42.95n/a16
Aug ’25€45.83
€51.40
+12.2%
11.3%€62.00€41.60n/a15
Jul ’25€44.19
€50.05
+13.3%
12.5%€62.00€40.55n/a16
Jun ’25€42.91
€49.30
+14.9%
11.0%€58.00€40.55n/a16
May ’25€43.35
€48.77
+12.5%
11.6%€58.00€40.55n/a16
Apr ’25€42.80
€48.77
+13.9%
11.6%€58.00€40.55n/a16
Mar ’25€40.48
€47.91
+18.4%
12.1%€58.00€37.84n/a16
Feb ’25€37.54
€47.47
+26.4%
12.1%€58.00€37.84n/a16
Jan ’25€35.92
€46.44
+29.3%
12.8%€55.00€32.86n/a16
Dec ’24€34.85
€46.22
+32.6%
13.4%€55.00€32.86€43.5816
Nov ’24€30.38
€47.28
+55.6%
12.0%€55.00€36.95€45.8116
Oct ’24€30.49
€47.92
+57.2%
12.3%€55.80€36.95€44.5516
Sep ’24€35.84
€48.59
+35.6%
11.2%€55.80€36.09€44.2416
Aug ’24€34.62
€47.61
+37.5%
11.2%€55.80€36.09€45.8314
Jul ’24€33.93
€48.00
+41.5%
10.6%€55.80€37.14€44.1916
Jun ’24€33.81
€48.51
+43.5%
9.7%€55.80€37.14€42.9116
May ’24€33.75
€48.91
+44.9%
8.1%€55.80€42.50€43.3516
Apr ’24€33.41
€48.97
+46.6%
8.3%€55.80€42.50€42.8015
Mar ’24€38.26
€49.16
+28.5%
8.2%€55.80€42.50€40.4816
Feb ’24€39.96
€49.23
+23.2%
8.4%€55.00€42.50€37.5416
Jan ’24€39.07
€49.58
+26.9%
6.7%€54.00€43.59€35.9216
Dec ’23€41.30
€49.38
+19.6%
6.6%€54.00€43.59€34.8515

Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.


Discover undervalued companies